Avitar Operating Income 1971-1970 | AVTI

Avitar operating income from 1971 to 1970. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Avitar Annual Operating Income
(Millions of US $)
Avitar Quarterly Operating Income
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
Avitar, Inc. (Avitar), through its wholly owned subsidiary Avitar Technologies, Inc. (ATI), develops, manufactures, markets and sells diagnostic test products and hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. The Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company's foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. The Company continues to have applications for its technologies in a variety of other medical/consumer markets. They include a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. Customers for these products include ArthroCare and National Aeronautics and Space Administration (NASA).
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.641B 24.25
Becton Dickinson (BDX) United States $59.276B 14.84
Cardinal Health (CAH) United States $33.781B 18.09
Labcorp (LH) United States $20.116B 16.32
Straumann Holding AG (SAUHY) Switzerland $19.852B 0.00
Cooper (COO) United States $16.444B 21.81
West Pharmaceutical Services (WST) United States $15.336B 32.15
Align Technology (ALGN) United States $13.013B 25.21
Henry Schein (HSIC) United States $8.105B 13.96
Merit Medical Systems (MMSI) United States $5.600B 27.07
DENTSPLY SIRONA (XRAY) United States $2.780B 8.35
CONMED (CNMD) United States $1.583B 12.30
STAAR Surgical (STAA) United States $0.918B 0.00
Pro-Dex (PDEX) United States $0.217B 33.03
Lifevantage (LFVN) United States $0.155B 17.15